NSE: MEDICO · PHARMACEUTICALS

Medico Remedies Limited Share Price & Company Info

₹18.31-0.70%

End-of-day price, · Educational content, not investment advice

52W low ₹18.8052W high ₹56.88
Market cap
₹154 Cras reported by NSE
52-week high
₹56.8824-DEC-2025
52-week low
₹18.8029-OCT-2026
P/E (NSE)
11.18
Face value
₹2.00
Shares issued
8,29,84,000
Volume
1,05,680₹0.19 Cr traded
Delivery
66.18%of traded quantity
Price band
10%₹17.09 – ₹20.87 on 2026-11-02
Annual volatility
68.01%NSE, from daily returns
Series
EQrolling settlement
BSE group
Bscrip code 540937
ISIN
INE630Y01024
Listed on NSE
26-May-2022

About Medico Remedies Limited

Medico Remedies Limited is listed on the National Stock Exchange of India under the symbol MEDICO in the EQ series. NSE classifies it under the basic industry Pharmaceuticals, part of the Healthcare sector. Its shares were listed on NSE on 26-May-2022. Each share has a face value of ₹2.00.

In the end-of-day data for 16 November 2026 the stock closed at ₹18.31, down 0.70% on the day. NSE puts the company's market capitalisation at about ₹154 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹18.80 and ₹56.88, so the last price is at or below the bottom of that range.

1,05,680 shares changed hands that day, and 66.18% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.

EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.

NSE currently lists a regulatory note for this stock: “LT ASM-1”. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.

NSE puts the stock's annualised volatility at 68.01%. That is very high: moves of several percent in a single day are routine.

Because the share trades below ₹20, it also appears in our list of penny stocks under ₹20, which explains the extra risks that come with low-priced shares.

Medico Remedies Limited quarterly results

In the quarter ended June 2026 (un-audited), Medico Remedies Limited reported total income of ₹70.57 crore and a net profit of ₹2.52 crore, or ₹0.30 per share. That is a net margin of 3.6% on income.

Compared with the previous quarter (March 2026), income rose 18.2%.

Medico Remedies Limited was profitable in 4 of the 4 quarters shown below, every one of them. Figures are as filed with NSE, in ₹ crore.

Quarterly results filed with NSE (₹ crore, EPS in ₹)
Quarter endedTotal incomeProfit before taxNet profitEPSStatus
June 202670.573.342.520.30Un-Audited
March 202659.688.325.860.71Un-Audited
December 202559.363.832.870.35Un-Audited
September 202554.363.472.570.31Un-Audited

Medico Remedies Limited shareholding pattern

At the end of September 2026, promoters and the promoter group held 61.38% of Medico Remedies Limited, with the public holding 38.62%. That is down 5.45 percentage points from 66.83% in December 2024.

A falling promoter stake is one of the things investors watch most closely in small companies, because it can signal insiders selling. The quarterly shareholding filings on NSE show who bought or sold.

Shareholding by category, as filed with NSE each quarter
Quarter endedPromoter & Promoter Group (%)Public (%)
September 202661.3838.62
June 202661.3838.62
March 202661.3838.62
December 202561.3838.62
September 202561.3838.62
June 202562.5937.41
March 202563.7936.21
December 202466.8333.17

Medico Remedies Limited share price performance

Over the past year the Medico Remedies Limited share price has lost 61.59%, against a fall of 10.92% for the NIFTY 50, so it has underperformed that index by 50.67 percentage points.

Across the 6 periods in the table, the stock did not beat the NIFTY 50 in any of them. Past returns describe what happened; they do not predict what comes next.

Price change by period, as of 2026-11-02 (NSE)
PeriodMEDICONIFTY 50
1 month-14.07%+1.91%
3 months-61.09%-5.20%
6 months-56.45%-3.94%
1 year-61.59%-10.92%
2 years-67.72%-5.29%
3 years-73.94%+20.44%

Medico Remedies Limited vs industry peers

NSE compares Medico Remedies Limited with 6 other listed companies in Pharmaceuticals. By market capitalisation it ranks 4 of 7.

Its P/E of 11.18 compares with a median of 13.50 for the other companies in the group.

NSE industry peer comparison, results for JUN 2026 quarter (₹ crore)
CompanyMarket capPrice (₹)P/EPromoter %Qtr incomeQtr net profit
NECLIFE20010.30—51.846.29-13.14
BMLL189150.00—67.70——
BROOKS17760.1513.5052.6223.141.42
MEDICO15418.5011.1861.3870.572.52
CURIS146180.0021.010.00——
NATCAPSUQ145138.99—50.9245.334.04
PAR141114.6710.8673.4132.224.71

Medico Remedies Limited announcements, board meetings and corporate actions

Latest announcements

The most recent filings Medico Remedies Limited has made with NSE, newest first:

  • 29-Sep-2026 · Price movement: Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Medico Remedies Limited has submitted their response. (PDF)
  • 29-Sep-2026 · Price movement: Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
  • 29-Sep-2026 · Trading Window: Medico Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
  • 23-Sep-2026 · Shareholders meeting: Medico Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange regarding voting results. (PDF)
  • 22-Sep-2026 · Shareholders meeting: Medico Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026 (PDF)
  • 29-Aug-2026 · General Updates: Medico Remedies Limited has informed the Exchange about Book Closure Dates. (PDF)
  • 29-Aug-2026 · Shareholders meeting: Medico Remedies Limited has informed the Exchange regarding Notice of undefined to be held on September 22, 2026 (PDF)
  • 13-Aug-2026 · Outcome of Board Meeting: Medico Remedies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. (PDF)

Board meetings

  • 13-Aug-2026 · Financial Results: To consider and approve the financial results for the period ended Jun 30, 2026
  • 21-May-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended March 31, 2026 and other business matters
  • 12-Feb-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended December 31, 2025 and other business matters
  • 14-Nov-2025 · Financial Results: To consider and approve the financial results for the period ended September 30, 2025
  • 08-Aug-2025 · Financial Results: To consider and approve the financial results for the period ended Jun 30, 2025

Corporate actions

The corporate actions on record include 1 share split. The ex-date is the first day the shares trade without the entitlement.

  • Annual General Meeting · ex-date 29-Aug-2024 · book closure 30-Aug-2024 to 05-Sep-2024
  • Annual General Meeting · ex-date 17-Aug-2023 · book closure 18-Aug-2023 to 24-Aug-2023
  • Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share · ex-date 16-Mar-2023 · record date 16-Mar-2023
  • Annual General Meeting · ex-date 13-Sep-2022 · book closure 15-Sep-2022 to 21-Sep-2022

Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Medico Remedies Limited.

Where to find Medico Remedies Limited's financials

Direct downloads from NSE:

For full financial statements, shareholding detail and every company announcement, go to the source:

Other Pharmaceuticals stocks on MCX Trends

Frequently asked questions

What is the Medico Remedies Limited share price?

Medico Remedies Limited (NSE: MEDICO) closed at ₹18.31 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.

Which sector does Medico Remedies Limited belong to?

NSE classifies Medico Remedies Limited under Pharmaceuticals, in the Healthcare sector.

What is the 52-week high and low of MEDICO?

The 52-week high is ₹56.88 (24-DEC-2025) and the 52-week low is ₹18.80 (29-OCT-2026), according to NSE.

Is Medico Remedies Limited a penny stock?

At ₹18.31 the share trades below ₹20, so it appears on our list of penny stocks under ₹20. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.

What is the promoter holding in Medico Remedies Limited?

Promoters and the promoter group held 61.38% of Medico Remedies Limited at the end of September 2026, according to the shareholding pattern filed with NSE.

What were Medico Remedies Limited's latest quarterly results?

For the quarter ended June 2026, Medico Remedies Limited reported total income of ₹70.57 crore and a net profit of ₹2.52 crore (EPS ₹0.30).

Where can I find Medico Remedies Limited's annual report and financial results?

Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for MEDICO) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.

More on MCX Trends